Tag: clinical trials

Performance Management & SLAs for Decentralized, Hybrid and Data-Heavy Clinical Trials Performance Management & SLAs for Decentralized, Hybrid and Data-Heavy Clinical Trials As clinical trials evolve, particularly in the context of decentralized and hybrid models, managing performance through Service Level Agreements (SLAs) becomes imperative. The increasing use of digital technologies and data-heavy processes necessitates rigorous…

Read More “Performance Management & SLAs for Decentralized, Hybrid and Data-Heavy Clinical Trials” »

Performance Management & SLAs: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs Performance Management & SLAs: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs In an environment where clinical research is becoming increasingly complex, effective performance management and the establishment of Service Level Agreements (SLAs) are pivotal in clinical trial outsourcing. This guide will provide…

Read More “Performance Management & SLAs: Clinical Trial Outsourcing Blueprint for Sponsors and Biotechs” »

How to Design Performance Management & SLAs for Global GCP-Compliant Clinical Programs In the realm of clinical trials, particularly for large pharmaceutical companies like Astellas, ensuring compliance with Good Clinical Practice (GCP) is paramount. A structured approach to performance management and Service Level Agreements (SLAs) is essential for successful oversight of clinical trials. This tutorial…

Read More “How to Design Performance Management & SLAs for Global GCP-Compliant Clinical Programs” »

Performance Management & SLAs in Clinical Trials: Best Practices for US, UK and EU Markets Performance Management & SLAs in Clinical Trials: Best Practices for US, UK and EU Markets In the evolving landscape of clinical trials, effective performance management and service level agreements (SLAs) play a pivotal role in ensuring that studies meet their…

Read More “Performance Management & SLAs in Clinical Trials: Best Practices for US, UK and EU Markets” »

Risk-Based Performance Management & SLAs: Reducing Cost Without Losing Quality or Control Risk-Based Performance Management & SLAs: Reducing Cost Without Losing Quality or Control Introduction to Risk-Based Performance Management in Clinical Trials In the realm of clinical trials, particularly for those utilizing the rave clinical trial model, effective risk-based performance management is essential for ensuring…

Read More “Risk-Based Performance Management & SLAs: Reducing Cost Without Losing Quality or Control” »

Performance Management & SLAs Strategies That Strengthen Vendor Oversight and Inspection Readiness Performance Management & SLAs Strategies That Strengthen Vendor Oversight and Inspection Readiness Introduction to Performance Management in Clinical Trials As clinical trials become more complex and the regulatory environment increasingly stringent, the importance of effective performance management in clinical trials cannot be overstated….

Read More “Performance Management & SLAs Strategies That Strengthen Vendor Oversight and Inspection Readiness” »